Home » Topics » Regulatory » Patents

Patents
RSS

Perimidine-based CRF antagonists developed at Agouron

June 9, 1998

BMS prepares novel sulfenamide taxane derivatives

June 9, 1998

Procter & Gamble R&D on metalloprotease inhibition

June 9, 1998

Merck & Co. research leads to novel vitronectin antagonists for osteoporosis, cancer, etc.

June 8, 1998

Sodium channel modulators under evaluation at Takeda

June 8, 1998

Dopamine agonists from AHP particularly useful in the treatment of schizophrenia

June 8, 1998

Lilly patents nonclassical antifolates for cancer, arthritis and psoriasis

June 8, 1998

Bronchotherapeutic agents in development at Byk Gulden

June 8, 1998

Fujisawa compounds lower blood cholesterol, triglyceride and lipid levels

June 5, 1998

Series of dopamine receptor subtype-selective ligands developed at Pfizer

June 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...